A novel approach to prevent HIV infection will be studied by ICAP in Mozambique’s Gaza Province, in collaboration with the World Health Organization (WHO) and with funding from the Bill and Melinda Gates Foundation. The study will assess the use of pre-exposure prophylaxis (PrEP) for the prevention of HIV acquisition by female partners of miners during periods of increased risk of infection.
ICAP has been awarded funding from the Centers for Disease Control and Prevention to support the Government of Sierra Leone’s response to health threats through health systems strengthening, enabling the country to respond effectively to emergent and future public health threats. This work will build on the lessons learned from the response to the current Ebola outbreak.
Results from the HPTN 067 study conducted at ICAP’s Harlem Prevention Center among other sites supported by the HIV Prevention Trials Network, reveal that men who have sex with men (MSM) and transgender women (TGW) at high risk of contracting HIV were able to adhere to a daily pre-exposure prophylaxis (PrEP) regimen to prevent HIV. The findings, which were shared at the 8th International AIDS Society Conference in Vancouver, Canada, are encouraging and indicate that populations at high risk for HIV are more likely to adhere to daily dosing versus non-daily dosing regimens of oral PrEP, currently available as Truvada®.
Eight fellows have been selected to participate in the third round of the Swaziland Health Research Training Program (HRTP). Fellows, who are already employed at governmental and educational institutions, will receive didactic training and mentorship in research implementation.
The Health Research Training Program, which launched in 2013, was established by the Government of the Kingdom of Swaziland’s Ministry of Health (MOH) and ICAP, with support from the CDC through PEPFAR. The program aims to broaden the skills of Swaziland’s mid-career public health professionals from government and partner institutions by equipping them with practical skills in protocol development, research implementation and monitoring, good clinical practice, data analysis, and scientific writing. Fellows also engage in skills building activities with mentors who have significant experience in research methods and implementation.
ICAP has received funding from the NIH to conduct a two-year study to evaluate retention and engagement in care among HIV-infected pregnant women receiving lifelong antiretroviral treatment—known as Option B+—at ten health facilities in Swaziland’s Manzini and Lubombo regions.
Through this study, ICAP is partnering with Swaziland’s Ministry of Health (MOH) to locate and engage approximately 600 women who initiated Option B+ in the context of ICAP’s Safe Generations study for the prevention of mother-to-child transmission (PMTCT) of HIV in order to determine challenges and facilitators to retention.
Friday and Saturday, July 18-19 7th International Workshop on HIV Pediatrics View full program Saturday, July 18 ICAP Pre-Conference Meeting Achieving Quality & Demonstrating Impact in Global HIV Programs View full program IAS ORAL and POSTER ABSTRACTS Monday, July 20 Hall B, West Exhibition Level A comparison of strategies to recruit Black men who have sex with men with undiagnosed HIV infection and/or unsuppressed viral load #MOPEC490 Ballroom C-D 2:30 – 4:00pm HPTN 067 ADAPT results from MSM in Harlem Sharon Mannheimer on behalf...